From here
Drug
companies and universities are spending 55.6 million euros ($72.7
million) to develop a bank of stem cells to use in testing potential
treatments for hard-to- treat diseases.
The
effort, known as Stembancc and managed by the University of Oxford in
England, will focus on generating 1,500 induced pluripotent stem cell
lines, researchers said at a London news conference. The cells will
be used by drugmakers including Pfizer Inc. (PFE), Sanofi (SAN) and
Roche Holding AG (ROG) to test treatments for peripheral nervous
disorders, pain, dementia, migraine, autism, schizophrenia, bipolar
disorder and diabetes and to perform toxicology tests.
Well, where is cancer? I
mean it was usually acceptable that stem cells treatments have to be
tested against cancer. The attempt of replacement of cancer tissue by
stem cells is at least imaginable. What has happened that stem cells
are not planned to be used against cancer?
The attempt of replacement
of cancer tissue by stem cells is at least imaginable. But how in the
world stem cells can be used for treatment of pain, dementia, migraine, autism, schizophrenia and
bipolar disorder??? Something is disconnected here...
No comments:
Post a Comment